SCH-23390

Last updated
SCH-23390
SCH 23390.svg
Names
IUPAC name
7-chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
PubChem CID
UNII
  • InChI=1S/C17H18ClNO/c1-19-8-7-13-9-16(18)17(20)10-14(13)15(11-19)12-5-3-2-4-6-12/h2-6,9-10,15,20H,7-8,11H2,1H3
    Key: GOTMKOSCLKVOGG-UHFFFAOYSA-N
  • (+):InChI=1S/C17H18ClNO/c1-19-8-7-13-9-16(18)17(20)10-14(13)15(11-19)12-5-3-2-4-6-12/h2-6,9-10,15,20H,7-8,11H2,1H3/t15-/m1/s1
    Key: GOTMKOSCLKVOGG-OAHLLOKOSA-N
  • CN1CCC2=CC(=C(C=C2C(C1)C3=CC=CC=C3)O)Cl
  • (+):CN1CCC2=CC(=C(C=C2[C@H](C1)C3=CC=CC=C3)O)Cl
Properties
C17H18ClNO
Molar mass 287.78 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X mark.svgN  verify  (what is  Yes check.svgYX mark.svgN ?)

SCH-23390, also known as halobenzazepine, is a synthetic compound that acts as a dopamine D1 receptor antagonist with either minimal or negligible effects on the D2 receptor.

In a 1990 study in rats SCH-23390 offered significant protection from death in dextroamphetamine overdose, without providing protection from death by methamphetamine overdose. The compound provided significant protection from cocaine overdose in rats only at the lowest dose tested in the measurement series. This suggested that dextroamphetamine and methamphetamine at high (lethal) doses have different mechanisms of toxicity in rats. [1]

CNS Review: [2]

See also

References

  1. Derlet, R. W.; Albertson, T. E.; Rice, P. (1990). "The Effect of SCH 23390 Against Toxic Doses of Cocaine, d-Amphetamine and Methamphetamine". Life Sciences. 47 (9): 821–827. doi:10.1016/0024-3205(90)90555-6. PMID   2215083.
  2. Bourne, J. A. (December 2001). "SCH 23390: The First Selective Dopamine D 1 -Like Receptor Antagonist". CNS Drug Reviews. 7 (4): 399–414. doi:10.1111/j.1527-3458.2001.tb00207.x. PMC   6741643 . PMID   11830757.